Ligon, Keith L.
Harvard Medical School,
United States
2025 Rank: 169269
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 6242 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 169269 | 180540 |
| Total Cites | 30240 | 34175 |
| H-index | 87 | 92 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 1082 | 1199 |
| Number of Single+First+Last Authored Papers | 23 | 23 |
| Total Cites to Single+First+Last Authored Papers | 2502 | 2823 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 25166 | 27396 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.25 |
| Self-Citation Percentage |
11.51%
|
|
Ligon, Keith L.
Dana-Farber Cancer Institute,
United States
2024 Rank: 164797
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 6158 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 164797 | 177270 |
| Total Cites | 27342 | 31023 |
| H-index | 83 | 88 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 1045 | 1162 |
| Number of Single+First+Last Authored Papers | 23 | 23 |
| Total Cites to Single+First+Last Authored Papers | 2340 | 2658 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 22875 | 24987 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.24 |
| Self-Citation Percentage |
11.87%
|
|
Ligon, Keith L.
Brigham and Women's Hospital,
United States
2023 Rank: 149852
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 5689 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 149852 | 160698 |
| Total Cites | 25377 | 28931 |
| H-index | 83 | 88 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 1001 | 1118 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 2615 | 2970 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 21138 | 23123 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.25 |
| Self-Citation Percentage |
12.28%
|
|
Ligon, Keith L.
Dana-Farber Cancer Institute,
United States
2022 Rank: 149982
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 5681 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 149982 | 160865 |
| Total Cites | 21775 | 24889 |
| H-index | 79 | 82 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 958 | 1072 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 2310 | 2637 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 18292 | 20046 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.24 |
| Self-Citation Percentage |
12.51%
|
|